Cargando…
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set
BACKGROUND: Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trial...
Autores principales: | Harman, Nicola L., Wilding, John, Curry, Dave, Harris, James, Logue, Jennifer, Pemberton, R. John, Perreault, Leigh, Thompson, Gareth, Tunis, Sean, Williamson, Paula R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081933/ https://www.ncbi.nlm.nih.gov/pubmed/30086771 http://dx.doi.org/10.1186/s13063-018-2805-2 |
Ejemplares similares
-
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
por: Harman, Nicola L, et al.
Publicado: (2019) -
SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials
por: Harman, Nicola L., et al.
Publicado: (2017) -
Incorporating patients’ perspectives into the initial stages of core outcome set development: a rapid review of qualitative studies of type 2 diabetes
por: Gorst, Sarah L, et al.
Publicado: (2019) -
Core Outcome Set-STAndards for Development: The COS-STAD recommendations
por: Kirkham, Jamie J., et al.
Publicado: (2017) -
The core outcome measures in effectiveness trials (COMET) initiative: five years on
por: Williamson, Paula, et al.
Publicado: (2015)